RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Cash and cash equivalents

AbbVie Inc.ABBV

Market cap
$405.4B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 20245,524-56.89%
Dec 31, 202312,814+39.27%
Dec 31, 20229,201-5.59%
Dec 31, 20219,746+15.35%
Dec 31, 20208,449-78.84%
Dec 31, 201939,924+447.73%
Dec 31, 20187,289-21.65%
Dec 31, 20179,303+82.41%
Dec 31, 20165,100-39.28%
Dec 31, 20158,399+0.61%
Dec 31, 20148,348-13.00%
Dec 31, 20139,595

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)